Skip to main content

Table 2 Eight scenarios of treatment effects for patients with different biomarker levels

From: IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy

 

Biomarker2

Level

1

2

3

4

1

2

3

4

Biomarker1

Scenario 1

Scenario 2

 1

0

0

0

0

1

1

1

1

 2

0

0

0

0

1

1

1

1

 3

0

0

0

0

1

1

1

1

 

Scenario 3

Scenario 4

 1

0

0

0

0

0

1

1

1

 2

0

0

0

0

1

1

1

1

 3

0

0

0

1

1

1

1

1

 

Scenario 5

Scenario 6

 1

0

0

0

0

0

0

1

1

 2

0

0

1

1

0

0

1

1

 3

0

0

1

1

1

1

1

1

 

Scenario 7

Scenario 8

 1

0

0

0

1

0

0.25

0.5

1

 2

0

0

1

1

0.25

0.5

1

1.25

 3

0

1

1

1

0.5

1

1.25

1.5

  1. Subgroups with clinically meaningful treatment effect are shown in boldface